CRT 2026
Coronary
Lorenzo Azzalini, MD, PhD, MSc
Interventional Cardiologist
University of Washington
Seattle, Washington, United States
Disclosure(s): Dr. Azzalini received consulting fees from Teleflex, Abiomed, GE Healthcare, Reflow Medical, Shockwave Medical, Abbott, Boston Scientific, XyloCor Therapeutics, HeartFlow, and Cardiovascular Systems, Inc.; and owns equity in Reflow Medical.: Consulting Fees (e.g., advisory boards) (Ongoing)
Brian Bergmark, MD
Interventional Cardiologist, Complex Coronary and CTO Program
Brigham and Women's Hospital, Harvard Medical School
Disclosure information not submitted.
Rhian E. Davies, DO MS
Interventional Cardiology
WellSpan York Hospital
Annville, Pennsylvania, United States
Disclosure(s): Terumo: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)